The RAVE token experienced an extraordinary 7,311% price surge in April, rising from $0.266 to $22.13, driven by heavy trading volume. However, this rally was highly volatile, with a sharp 46% correction within a day, and allegations of price manipulation surfaced. Despite denials from the company, investigations were launched by exchanges. The token's price has since collapsed below $0.6, erasing all gains and entering a downtrend, with potential further declines to $0.30 if the $0.6 support level fails to hold. The token's future remains uncertain, heavily influenced by social sentiment and market trust.
Mesoblast Limited has drawn $50 million from a new five-year loan facility provided by a shareholder, replacing higher-cost short-term debt. This move strengthens Mesoblast's balance sheet by lowering interest costs and removing short-term obligation...
HUTCHMED announced positive Phase II trial results for fanregratinib in treating advanced intrahepatic cholangiocarcinoma (ICC) with FGFR2 fusion/rearrangement. The study showed a 42.5% objective response rate and median overall survival of 16.6 mont...
Western Union and Intermex announced that regulatory approvals for Western Union's acquisition of Intermex have been received from 51 U.S. states and international jurisdictions, with only one U.S. state, New York, pending approval. Both companies ar...
Modern Therapy Group has introduced a virtual intensive outpatient program (IOP) designed for adults dealing with depression, anxiety, trauma, and other mental health issues. This program offers structured, clinician-led treatment five days a week vi...
Meyer Wilson Werning, an investor protection law firm, is investigating UBS advisor Daniel Merithew Allen for allegedly recommending unapproved investments in 99 Acquisition Group LLC to clients. This practice, known as "selling away," violates FINRA...
